Candida albicans is a type of fungus that lives naturally in and on the human body. It resides in the mouth, gut, and vaginal tract of most healthy people without causing any problems. But under certain conditions, it can multiply beyond its usual numbers and cause infections ranging from mild thrush to life-threatening bloodstream infections.
A Fungus That Lives in Two Forms
What makes Candida albicans unusual is its ability to switch between two physical forms. In its harmless state, it grows as round yeast cells that bud off new cells, much like baker’s yeast. But when triggered by changes in its environment, it can shift into an elongated, thread-like form called hyphae. These threads can physically penetrate tissue, which is a key reason C. albicans can transition from a peaceful resident of your body to an invader.
This shape-shifting happens rapidly. A round yeast cell sprouts a tube-like extension, and its genetic material migrates into the growing thread before dividing. One copy stays in the original cell, the other pushes forward into the extending filament. The ability to toggle between these two growth modes is central to how C. albicans causes disease: the yeast form spreads easily through the bloodstream, while the hyphal form burrows into tissue and helps the fungus resist immune cells.
Where It Lives in Healthy People
Candida species colonize the skin and mucosal surfaces of healthy people as part of the normal microbiome. In the mouth alone, yeast can be detected in up to 70% of healthy individuals, and when researchers identify which species is present, C. albicans dominates. One study found it accounted for over 94% of oral yeast isolates. It also lives in the gastrointestinal tract and the vagina, where it coexists with bacteria that keep its numbers in check.
Most people carry C. albicans their entire lives without ever knowing it. The fungus only becomes a problem when something disrupts the balance, whether that’s a weakened immune system, a course of antibiotics, or a shift in the body’s chemistry.
What Triggers an Overgrowth
The most common trigger is antibiotics. Broad-spectrum antibiotics kill off the bacteria that normally compete with Candida for space and nutrients. Research published in Nature Reviews Microbiology showed that antibiotic-induced disruption of gut bacteria also impairs a specific arm of the immune system (a type of immune cell response that maintains the gut barrier), creating a double hit: less bacterial competition and a weaker defense.
High blood sugar is another major factor. Glucose concentration is directly related to how fast C. albicans multiplies. Studies on diabetic patients have shown that elevated blood sugar allows the fungus to grow even in the presence of normal bacterial flora, and it also makes the organism more resistant to oxidative stress and certain antifungal drugs. This is why people with poorly controlled diabetes are significantly more prone to yeast infections.
Other common triggers include pregnancy, oral contraceptives, corticosteroids, and any condition that suppresses the immune system, such as HIV or chemotherapy.
Common Infections and Their Symptoms
The vast majority of Candida infections are superficial, meaning they affect the skin or the lining of the mouth, throat, or vagina.
Oral Thrush
Thrush appears as white patches on the inner cheeks, tongue, roof of the mouth, or throat. It can cause redness, soreness, a cotton-like feeling in the mouth, loss of taste, and pain while eating or swallowing. Cracking at the corners of the mouth is also common. When the infection extends into the esophagus, it causes pain and difficulty swallowing.
Vaginal Yeast Infections
Vaginal candidiasis causes itching or soreness, pain during sex or urination, and abnormal discharge. Most cases are mild and resolve with treatment, but some women develop severe infections with redness, swelling, and cracks in the vaginal wall. About 75% of women will experience at least one vaginal yeast infection in their lifetime.
When It Becomes Dangerous
Invasive candidiasis occurs when the fungus enters the bloodstream, joints, or internal organs. This is almost exclusively a hospital-acquired problem, affecting patients who are already seriously ill. Surgical wounds, catheters, central venous lines, and ventilators all create entry points for Candida to bypass the body’s outer defenses.
The stakes are high. About one third of patients with Candida in the bloodstream die during their hospitalization. Even after accounting for how sick these patients already were, researchers estimate that the Candida infection itself is responsible for 19% to 24% of those deaths, according to CDC surveillance data.
How It’s Diagnosed
For superficial infections like thrush or vaginal yeast infections, a healthcare provider can often diagnose based on symptoms and a simple swab examined under a microscope.
Invasive infections are harder to catch. Traditional blood cultures, the standard method, are surprisingly insensitive. They detect only about 38% of cases with proven or probable invasive candidiasis. PCR-based tests, which look for the fungus’s genetic material, perform far better, with sensitivity around 95% and specificity around 92% for bloodstream infections. The gap is significant: PCR picks up 85% of proven or probable cases compared to 38% for cultures. However, PCR testing is not yet universally available in all hospitals.
How It Holds On: Biofilms and Virulence
C. albicans has a toolkit that helps it survive and cause damage. Its surface is studded with adhesion proteins that let it stick to human tissue and to medical devices like catheters. Once attached, it can form biofilms, which are structured communities of cells encased in a protective matrix. Biofilms are notoriously difficult for the immune system and antifungal drugs to penetrate.
The fungus also secretes enzymes that break down host tissue. It produces a family of at least ten protein-digesting enzymes, eight of which are released into surrounding tissue where they degrade proteins and help the fungus invade deeper. It also produces fat-digesting enzymes that aid in tissue penetration. These virulence tools, combined with the ability to switch to the invasive hyphal form, make C. albicans the most medically significant Candida species.
Treatment Options
Antifungal medications fall into a few main classes, each targeting a different part of the fungal cell. The most commonly prescribed are azoles (fluconazole being the most familiar), which block the production of a key component in the fungal cell membrane. Azoles don’t kill the fungus outright but stop it from growing, giving the immune system time to clear the infection. For mild thrush or a vaginal yeast infection, a short course of an azole, either as a pill or a topical cream, is the standard first step.
For more serious infections, two other classes come into play. Polyenes punch holes in the fungal cell membrane and are directly lethal to the fungus. Echinocandins take a different approach, disrupting the structural integrity of the fungal cell wall. Both are typically given intravenously for invasive infections.
Resistance remains relatively low in C. albicans compared to some of its relatives. In a recent study of over 400 Candida isolates, only about 3% of C. albicans samples were resistant to fluconazole. Other species, particularly C. tropicalis, showed much higher resistance rates. Still, resistance is a growing concern across all Candida species, which is one reason clinicians take care to identify exactly which species is causing an infection before choosing a treatment.
Why Blood Sugar Matters
If you’re prone to recurrent yeast infections, blood sugar control is one of the most actionable factors you can address. Because C. albicans grows faster in proportion to available glucose, even moderately elevated blood sugar creates a more hospitable environment for the fungus. This applies not only to people with diabetes but also to anyone experiencing temporary glucose spikes from medications like corticosteroids. Keeping blood sugar within a normal range reduces both the frequency and severity of Candida overgrowth.